Where does OBP Medical Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), OBP Medical Corporation ranks #12,149 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does OBP Medical Corporation hold?

OBP Medical Corporation holds 25 US utility patents granted between 2015 and 2023, spanning 6 technology areas.

What is OBP Medical Corporation's Innovation Score?

OBP Medical Corporation has an Innovation Score of 32.4 out of 100 (41st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does OBP Medical Corporation focus on?

OBP Medical Corporation's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 21 patents, ranking #851 of 7,127 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is OBP Medical Corporation's patent grant rate increasing or decreasing?

OBP Medical Corporation's recent grant velocity is +27% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for OBP Medical Corporation's patents?

OBP Medical Corporation's patents average 19.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the OBP Medical Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

OBP Medical Corporation

USPTO PatentsView assignee record - 25 granted patents across 6 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, OBP ranks #12,149 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 6 technology areas.

#12,149
of 49,997 US assignees by volume: 41st percentile
by Innovation Score (32.4/100): 19.6
avg claims per patent: +27%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12149 · US Corporation #12,149 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 25 grants
UPPER-Q #12,149/49,997
PHOTO-FINISH Nora Lighting
CPC-NARROW A61B · 6 areas
INNOV-THIN 32.4/100
CLAIMS-RICH 19.6 claims/avg
TYPE-USCORP US Corporation
VEL-UP +27% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nora Lighting, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How OBP’s 32.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.3 pts (35%) Velocity 0.7 pts (2%) Breadth 8.7 pts (27%) Claim depth 11.8 pts (36%)

Qualcomm Incorporated · highest

85
Aica Kogyo · near

32
C Rob Hammerstein & KG · near

32
OBP Medical · this assignee

32
University of… · near

32
NEC Lighting · near

32
3D Lighting… · lowest

7

What this shows OBP's Innovation Score is 32.4/100 (41st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for OBP?

Each dot is one of OBP’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). OBP’s own 19.6 claims/patent is ABOVE the 17.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

OBP vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where OBP's grants concentrate

OBP Medical Corporation is a focused PatentsView assignee: 6 CPC subclasses with 84% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2021 (8 grants) versus a trough of 1 in 2016. By volume, OBP sits between Nora Lighting, Inc. and Obalon Therapeutics, Inc..

OBP's three-year grant acceleration

OBP Medical Corporation shows 2 grants in 2022–2024 against only 18 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nora Lighting

25
Norma U S Holding

25
Nuvaira

25
OBI Pharma

25
Opko Ireland Glob…

25
Optimizely

25
OPW Fueling Compo…

25
Obalon Therapeuti…

25
OBP Medical ◀

25

What this shows OBP holds 25 patents at rank #12,145, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near OBP

By rank, the assignees closest to #12,145 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in OBP's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for OBP, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), OBP ranks #851 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (32 here).

University of Florida Foundation, Incorporated 32 C. Rob. Hammerstein GmbH & Co. KG 32 Aica Kogyo Co., Ltd. 32 NEC Lighting, Ltd. 32

OBP's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 41st percentile higher than 41% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

OBP Medical Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	8.0%
2016	1	4.0%
2018	2	8.0%
2019	6	24.0%
2020	4	16.0%
2021	8	32.0%
2022	1	4.0%
2023	1	4.0%

Which technologies does OBP Medical Corporation patent most?

A61B - DIAGNOSIS; SURGERY; Identification 21

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

H05K - Printed CIRCUITS; Casings OR Constructional Details OF Electric APPARATUS; Manufacture OF Assemblages OF Electrical Components 2

F21V - Functional Features OR Details OF Lighting Devices OR Systems THEREOF; Structural Combinations OF Lighting Devices With Other Articles, NOT Otherwise Provided FOR 1

F21Y - Indexing Scheme Associated With Subclasses F21k, F21l, F21s and F21v, Relating TO THE Form OR THE Kind OF THE Light Sources OR OF THE Colour OF THE Light Emitted 1

F21W - Indexing Scheme Associated With Subclasses F21k, F21l, F21s and F21v, Relating TO Uses OR Applications OF Lighting Devices OR Systems 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

OBP Medical Corporation's patent record in context - here's where to go next.

OBP Medical Corporation's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 84% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #12,149 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare OBP Medical Corporation against Nora Lighting, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.